Enthera Pharmaceuticals ("Enthera"), a clinical-stage biotech company developing a first-in-class antibody therapeutic targeting the Insulin Growth Factor Binding Protein 3 (IGFBP3)/TMEM219 pathway ...

In many neurodegenerative diseases, proteins misfold and clump together in brain tissue. Scientists developed a new therapy made of peptides and a sugar that naturally occurs in plants. The ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...

FuturHealth offers both compounded semaglutide and FDA-approved name-brand options like Wegovy and Ozempic. For most users, ...

Novo has a strong balance sheet and ended 2024 with about DKK 26 billion in cash and marketable securities and DKK 103 billion of debt (following the acquisition of Catalent manufacturing sites in ...

Discover How Arialief Alleviates Nerve Pain, Supports Metabolic Health, and Enhances Mobility-Without the Side Effects of ...

Eric “Eruption” Tai took to social media to share an inspiring before-and-after photo showing his stunning 27-pound weight ...

Researchers are getting better at growing miniature organs and embryos in test tubes or on chips. This creates new ...

One of the greatest transformations in modern medicine arguably began with a corned beef sandwich.It was the late 1960s, and ...

This study identifies 53BP1 as an interaction partner of GMCL1 (a likely CUL3 substrate receptor). The study seeks to link this finding to regulation of the mitotic surveillance pathway and paclitaxel ...

"A lot of research groups are making very novel designs of implantable devices, but almost every research group is using a similar model and is facing a similar ... building out the rest of the ...